Skip to main content
NCBI home page
The EMBO Journal logoLink to The EMBO Journal
. 1998 Aug 3;17(15):4358–4369. doi: 10.1093/emboj/17.15.4358

Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.

S Huang 1, D Jean 1, M Luca 1, M A Tainsky 1, M Bar-Eli 1
PMCID: PMC1170769  PMID: 9687504

Abstract

Expression of the tyrosine kinase receptor, c-KIT, progressively decreases during local tumor growth and invasion of human melanomas. We have previously shown that enforced c-KIT expression in highly metastatic cells inhibited tumor growth and metastasis in nude mice. Furthermore, the ligand for c-KIT, SCF, induces apoptosis in human melanoma cells expressing c-KIT under both in vitro and in vivo conditions. Here we show that loss of c-KIT expression in highly metastatic cells correlates with loss of expression of the transcription factor AP-2. The c-KIT promoter contains three binding sites for AP-2 and EMSA gels demonstrated that AP-2 protein binds directly to the c-KIT promoter. Transfection of wild-type AP-2 into c-KIT-negative A375SM melanoma cells activated a c-KIT promoter-driven luciferase reporter gene, while expression of a dominant-negative AP-2B in c-KIT-positive Mel-501 cells inhibited its activation. Endogenous c-KIT mRNA and expression of proteins were upregulated in AP-2-transfected cells, but not in control cells. In addition, re-expression of AP-2 in A375SM cells suppressed their tumorigenicity and metastatic potential in nude mice. These results indicate that the expression of c-KIT is highly regulated by AP-2 and that enforced AP-2 expression suppresses tumorigenicity and metastatic potential of human melanoma cells, possibly through c-KIT transactivation and SCF-induced apoptosis. Therefore, loss of AP-2 expression might be a crucial event in the development of malignant melanoma.

Full Text

The Full Text of this article is available as a PDF (417.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ariizumi K., Bergstresser P. R., Takashima A. Wavelength-specific induction of immediate early genes by ultraviolet radiation. J Dermatol Sci. 1996 Jun;12(2):147–155. doi: 10.1016/0923-1811(95)00474-2. [DOI] [PubMed] [Google Scholar]
  2. Bar-Eli M. Molecular mechanisms of melanoma metastasis. J Cell Physiol. 1997 Nov;173(2):275–278. doi: 10.1002/(SICI)1097-4652(199711)173:2<275::AID-JCP35>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  3. Bauer R., Imhof A., Pscherer A., Kopp H., Moser M., Seegers S., Kerscher M., Tainsky M. A., Hofstaedter F., Buettner R. The genomic structure of the human AP-2 transcription factor. Nucleic Acids Res. 1994 Apr 25;22(8):1413–1420. doi: 10.1093/nar/22.8.1413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bosher J. M., Williams T., Hurst H. C. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):744–747. doi: 10.1073/pnas.92.3.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brannan C. I., Lyman S. D., Williams D. E., Eisenman J., Anderson D. M., Cosman D., Bedell M. A., Jenkins N. A., Copeland N. G. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4671–4674. doi: 10.1073/pnas.88.11.4671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Buettner R., Kannan P., Imhof A., Bauer R., Yim S. O., Glockshuber R., Van Dyke M. W., Tainsky M. A. An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol Cell Biol. 1993 Jul;13(7):4174–4185. doi: 10.1128/mcb.13.7.4174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carthew R. W., Chodosh L. A., Sharp P. A. An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter. Cell. 1985 Dec;43(2 Pt 1):439–448. doi: 10.1016/0092-8674(85)90174-6. [DOI] [PubMed] [Google Scholar]
  8. Chabot B., Stephenson D. A., Chapman V. M., Besmer P., Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature. 1988 Sep 1;335(6185):88–89. doi: 10.1038/335088a0. [DOI] [PubMed] [Google Scholar]
  9. Copeman M. C. The putative melanoma tumor-suppressor gene on human chromosome 6q. Pathology. 1992 Oct;24(4):307–309. doi: 10.3109/00313029209068886. [DOI] [PubMed] [Google Scholar]
  10. Cowley G. P., Smith M. E. Cadherin expression in melanocytic naevi and malignant melanomas. J Pathol. 1996 Jun;179(2):183–187. doi: 10.1002/(SICI)1096-9896(199606)179:2<183::AID-PATH554>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
  11. Descheemaeker K. A., Wyns S., Nelles L., Auwerx J., Ny T., Collen D. Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response. J Biol Chem. 1992 Jul 25;267(21):15086–15091. [PubMed] [Google Scholar]
  12. Duan C., Clemmons D. R. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J Biol Chem. 1995 Oct 20;270(42):24844–24851. doi: 10.1074/jbc.270.42.24844. [DOI] [PubMed] [Google Scholar]
  13. Fidler I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 1990 Oct 1;50(19):6130–6138. [PubMed] [Google Scholar]
  14. Flanagan J. G., Chan D. C., Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell. 1991 Mar 8;64(5):1025–1035. doi: 10.1016/0092-8674(91)90326-t. [DOI] [PubMed] [Google Scholar]
  15. Fleischman R. A. Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene. J Clin Invest. 1992 Jun;89(6):1713–1717. doi: 10.1172/JCI115772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fleischman R. A., Saltman D. L., Stastny V., Zneimer S. Deletion of the c-kit protooncogene in the human developmental defect piebald trait. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10885–10889. doi: 10.1073/pnas.88.23.10885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fort P., Marty L., Piechaczyk M., el Sabrouty S., Dani C., Jeanteur P., Blanchard J. M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985 Mar 11;13(5):1431–1442. doi: 10.1093/nar/13.5.1431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992 Nov;119(3):493–501. doi: 10.1083/jcb.119.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gaynor R. B., Muchardt C., Xia Y. R., Klisak I., Mohandas T., Sparkes R. S., Lusis A. J. Localization of the gene for the DNA-binding protein AP-2 to human chromosome 6p22.3-pter. Genomics. 1991 Aug;10(4):1100–1102. doi: 10.1016/0888-7543(91)90209-w. [DOI] [PubMed] [Google Scholar]
  20. Geissler E. N., Ryan M. A., Housman D. E. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell. 1988 Oct 7;55(1):185–192. doi: 10.1016/0092-8674(88)90020-7. [DOI] [PubMed] [Google Scholar]
  21. Giebel L. B., Spritz R. A. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8696–8699. doi: 10.1073/pnas.88.19.8696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Grether-Beck S., Olaizola-Horn S., Schmitt H., Grewe M., Jahnke A., Johnson J. P., Briviba K., Sies H., Krutmann J. Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14586–14591. doi: 10.1073/pnas.93.25.14586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Grover R., Wilson G. D. Bcl-2 expression in malignant melanoma and its prognostic significance. Eur J Surg Oncol. 1996 Aug;22(4):347–349. doi: 10.1016/s0748-7983(96)90176-6. [DOI] [PubMed] [Google Scholar]
  24. Gutman M., Singh R. K., Radinsky R., Bar-Eli M. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities. Anticancer Res. 1994 Sep-Oct;14(5A):1759–1765. [PubMed] [Google Scholar]
  25. Haslinger A., Karin M. Upstream promoter element of the human metallothionein-IIA gene can act like an enhancer element. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8572–8576. doi: 10.1073/pnas.82.24.8572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Healy E., Rehman I., Angus B., Rees J. L. Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosomes Cancer. 1995 Feb;12(2):152–156. doi: 10.1002/gcc.2870120211. [DOI] [PubMed] [Google Scholar]
  27. Holman C. D., Mulroney C. D., Armstrong B. K. Epidemiology of pre-invasive and invasive malignant melanoma in Western Australia. Int J Cancer. 1980 Mar 15;25(3):317–323. doi: 10.1002/ijc.2910250303. [DOI] [PubMed] [Google Scholar]
  28. Huang S., Luca M., Gutman M., McConkey D. J., Langley K. E., Lyman S. D., Bar-Eli M. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene. 1996 Dec 5;13(11):2339–2347. [PubMed] [Google Scholar]
  29. Hudson J. M., Frade R., Bar-Eli M. Wild-type p53 regulates its own transcription in a cell-type specific manner. DNA Cell Biol. 1995 Sep;14(9):759–766. doi: 10.1089/dna.1995.14.759. [DOI] [PubMed] [Google Scholar]
  30. Hyman S. E., Comb M., Pearlberg J., Goodman H. M. An AP-2 element acts synergistically with the cyclic AMP- and phorbol ester-inducible enhancer of the human proenkephalin gene. Mol Cell Biol. 1989 Jan;9(1):321–324. doi: 10.1128/mcb.9.1.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Janknecht R., Hunter T. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J. 1997 Apr 1;16(7):1620–1627. doi: 10.1093/emboj/16.7.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Jean D., Gershenwald J. E., Huang S., Luca M., Hudson M. J., Tainsky M. A., Bar-Eli M. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. J Biol Chem. 1998 Jun 26;273(26):16501–16508. doi: 10.1074/jbc.273.26.16501. [DOI] [PubMed] [Google Scholar]
  33. Jiang H., Lin J., Su Z. Z., Herlyn M., Kerbel R. S., Weissman B. E., Welch D. R., Fisher P. B. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene. 1995 May 4;10(9):1855–1864. [PubMed] [Google Scholar]
  34. Kannan P., Buettner R., Chiao P. J., Yim S. O., Sarkiss M., Tainsky M. A. N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev. 1994 Jun 1;8(11):1258–1269. doi: 10.1101/gad.8.11.1258. [DOI] [PubMed] [Google Scholar]
  35. Kopf A. W., Salopek T. G., Slade J., Marghoob A. A., Bart R. S. Techniques of cutaneous examination for the detection of skin cancer. Cancer. 1995 Jan 15;75(2 Suppl):684–690. doi: 10.1002/1097-0142(19950115)75:2+<684::aid-cncr2820751411>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  36. Kozlowski J. M., Hart I. R., Fidler I. J., Hanna N. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Cancer Inst. 1984 Apr;72(4):913–917. [PubMed] [Google Scholar]
  37. Lassam N., Bickford S. Loss of c-kit expression in cultured melanoma cells. Oncogene. 1992 Jan;7(1):51–56. [PubMed] [Google Scholar]
  38. Leask A., Byrne C., Fuchs E. Transcription factor AP2 and its role in epidermal-specific gene expression. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):7948–7952. doi: 10.1073/pnas.88.18.7948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Lee W., Haslinger A., Karin M., Tjian R. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature. 1987 Jan 22;325(6102):368–372. doi: 10.1038/325368a0. [DOI] [PubMed] [Google Scholar]
  40. Lehmann J. M., Riethmüller G., Johnson J. P. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9891–9895. doi: 10.1073/pnas.86.24.9891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Li L., Price J. E., Fan D., Zhang R. D., Bucana C. D., Fidler I. J. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. J Natl Cancer Inst. 1989 Sep 20;81(18):1406–1412. doi: 10.1093/jnci/81.18.1406. [DOI] [PubMed] [Google Scholar]
  42. Luca M., Huang S., Gershenwald J. E., Singh R. K., Reich R., Bar-Eli M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol. 1997 Oct;151(4):1105–1113. [PMC free article] [PubMed] [Google Scholar]
  43. Luca M., Hunt B., Bucana C. D., Johnson J. P., Fidler I. J., Bar-Eli M. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res. 1993 Feb;3(1):35–41. doi: 10.1097/00008390-199304000-00006. [DOI] [PubMed] [Google Scholar]
  44. Luca M., Xie S., Gutman M., Huang S., Bar-Eli M. Abnormalities in the CDKN2 (p16INK4/MTS-1) gene in human melanoma cells: relevance to tumor growth and metastasis. Oncogene. 1995 Oct 5;11(7):1399–1402. [PubMed] [Google Scholar]
  45. Lüscher B., Mitchell P. J., Williams T., Tjian R. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev. 1989 Oct;3(10):1507–1517. doi: 10.1101/gad.3.10.1507. [DOI] [PubMed] [Google Scholar]
  46. Mitchell P. J., Timmons P. M., Hébert J. M., Rigby P. W., Tjian R. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 1991 Jan;5(1):105–119. doi: 10.1101/gad.5.1.105. [DOI] [PubMed] [Google Scholar]
  47. Mitchell P. J., Wang C., Tjian R. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell. 1987 Sep 11;50(6):847–861. doi: 10.1016/0092-8674(87)90512-5. [DOI] [PubMed] [Google Scholar]
  48. Naeve G. S., Sharma A., Lee A. S. Identification of a 10-base pair protein binding site in the promoter of the hamster H3.2 gene required for the S phase dependent increase in transcription and its interaction with a Jun-like nuclear factor. Cell Growth Differ. 1992 Dec;3(12):919–928. [PubMed] [Google Scholar]
  49. Natali P. G., Nicotra M. R., Digiesi G., Cavaliere R., Bigotti A., Trizio D., Segatto O. Expression of gp185HER-2 in human cutaneous melanoma: implications for experimental immunotherapeutics. Int J Cancer. 1994 Feb 1;56(3):341–346. doi: 10.1002/ijc.2910560308. [DOI] [PubMed] [Google Scholar]
  50. Natali P. G., Nicotra M. R., Winkler A. B., Cavaliere R., Bigotti A., Ullrich A. Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor. Int J Cancer. 1992 Sep 9;52(2):197–201. doi: 10.1002/ijc.2910520207. [DOI] [PubMed] [Google Scholar]
  51. Nishikawa S., Kusakabe M., Yoshinaga K., Ogawa M., Hayashi S., Kunisada T., Era T., Sakakura T., Nishikawa S. In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development. EMBO J. 1991 Aug;10(8):2111–2118. doi: 10.1002/j.1460-2075.1991.tb07744.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Nocka K., Majumder S., Chabot B., Ray P., Cervone M., Bernstein A., Besmer P. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice. Genes Dev. 1989 Jun;3(6):816–826. doi: 10.1101/gad.3.6.816. [DOI] [PubMed] [Google Scholar]
  53. Nocka K., Tan J. C., Chiu E., Chu T. Y., Ray P., Traktman P., Besmer P. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 1990 Jun;9(6):1805–1813. doi: 10.1002/j.1460-2075.1990.tb08305.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Nyborg J. K., Dynan W. S. Interaction of cellular proteins with the human T-cell leukemia virus type I transcriptional control region. Purification of cellular proteins that bind the 21-base pair repeat elements. J Biol Chem. 1990 May 15;265(14):8230–8236. [PubMed] [Google Scholar]
  55. Orr-Urtreger A., Avivi A., Zimmer Y., Givol D., Yarden Y., Lonai P. Developmental expression of c-kit, a proto-oncogene encoded by the W locus. Development. 1990 Aug;109(4):911–923. doi: 10.1242/dev.109.4.911. [DOI] [PubMed] [Google Scholar]
  56. Pathak S., Drwinga H. L., Hsu T. C. Involvement of chromosome 6 in rearrangements in human malignant melanoma cell lines. Cytogenet Cell Genet. 1983;36(3):573–579. doi: 10.1159/000131975. [DOI] [PubMed] [Google Scholar]
  57. Radinsky R., Fidler I. J., Price J. E., Esumi N., Tsan R., Petty C. M., Bucana C. D., Bar-Eli M. Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene. 1994 Jul;9(7):1877–1883. [PubMed] [Google Scholar]
  58. Reith A. D., Rottapel R., Giddens E., Brady C., Forrester L., Bernstein A. W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. Genes Dev. 1990 Mar;4(3):390–400. doi: 10.1101/gad.4.3.390. [DOI] [PubMed] [Google Scholar]
  59. Romerdahl C. A., Donawho C., Fidler I. J., Kripke M. L. Effect of ultraviolet-B radiation on the in vivo growth of murine melanoma cells. Cancer Res. 1988 Jul 15;48(14):4007–4010. [PubMed] [Google Scholar]
  60. Schorle H., Meier P., Buchert M., Jaenisch R., Mitchell P. J. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature. 1996 May 16;381(6579):235–238. doi: 10.1038/381235a0. [DOI] [PubMed] [Google Scholar]
  61. Singh R. K., Gutman M., Reich R., Bar-Eli M. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res. 1995 Aug 15;55(16):3669–3674. [PubMed] [Google Scholar]
  62. Tan J. C., Nocka K., Ray P., Traktman P., Besmer P. The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science. 1990 Jan 12;247(4939):209–212. doi: 10.1126/science.1688471. [DOI] [PubMed] [Google Scholar]
  63. Trent J. M., Stanbridge E. J., McBride H. L., Meese E. U., Casey G., Araujo D. E., Witkowski C. M., Nagle R. B. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science. 1990 Feb 2;247(4942):568–571. doi: 10.1126/science.2300817. [DOI] [PubMed] [Google Scholar]
  64. Trent J. M., Thompson F. H., Meyskens F. L., Jr Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma. Cancer Res. 1989 Jan 15;49(2):420–423. [PubMed] [Google Scholar]
  65. Vidal M. J., Loganzo F., Jr, de Oliveira A. R., Hayward N. K., Albino A. P. Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas. Melanoma Res. 1995 Aug;5(4):243–250. doi: 10.1097/00008390-199508000-00006. [DOI] [PubMed] [Google Scholar]
  66. Walker G. J., Nancarrow D. J., Walters M. K., Palmer J. M., Weber J. L., Hayward N. K. Linkage analysis in familial melanoma kindreds to markers on chromosome 6p. Int J Cancer. 1994 Dec 15;59(6):771–775. doi: 10.1002/ijc.2910590611. [DOI] [PubMed] [Google Scholar]
  67. Welch D. R., Chen P., Miele M. E., McGary C. T., Bower J. M., Stanbridge E. J., Weissman B. E. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene. 1994 Jan;9(1):255–262. [PubMed] [Google Scholar]
  68. Williams T., Admon A., Lüscher B., Tjian R. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev. 1988 Dec;2(12A):1557–1569. doi: 10.1101/gad.2.12a.1557. [DOI] [PubMed] [Google Scholar]
  69. Williams T., Tjian R. Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. Science. 1991 Mar 1;251(4997):1067–1071. doi: 10.1126/science.1998122. [DOI] [PubMed] [Google Scholar]
  70. Xie S., Luca M., Huang S., Gutman M., Reich R., Johnson J. P., Bar-Eli M. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res. 1997 Jun 1;57(11):2295–2303. [PubMed] [Google Scholar]
  71. Xie S., Price J. E., Luca M., Jean D., Ronai Z., Bar-Eli M. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells. Oncogene. 1997 Oct 23;15(17):2069–2075. doi: 10.1038/sj.onc.1201358. [DOI] [PubMed] [Google Scholar]
  72. Yamamoto K., Tojo A., Aoki N., Shibuya M. Characterization of the promoter region of the human c-kit proto-oncogene. Jpn J Cancer Res. 1993 Nov;84(11):1136–1144. doi: 10.1111/j.1349-7006.1993.tb02813.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Yarden Y., Kuang W. J., Yang-Feng T., Coussens L., Munemitsu S., Dull T. J., Chen E., Schlessinger J., Francke U., Ullrich A. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 1987 Nov;6(11):3341–3351. doi: 10.1002/j.1460-2075.1987.tb02655.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Zakut R., Perlis R., Eliyahu S., Yarden Y., Givol D., Lyman S. D., Halaban R. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene. 1993 Aug;8(8):2221–2229. [PubMed] [Google Scholar]
  75. Zeng Y. X., Somasundaram K., el-Deiry W. S. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat Genet. 1997 Jan;15(1):78–82. doi: 10.1038/ng0197-78. [DOI] [PubMed] [Google Scholar]
  76. Zhang J., Cui P., Glatfelter A. A., Cummings L. M., Meltzer P. S., Trent J. M. Microdissection based cloning of a translocation breakpoint in a human malignant melanoma. Cancer Res. 1995 Oct 15;55(20):4640–4645. [PubMed] [Google Scholar]
  77. Zhang J., Hagopian-Donaldson S., Serbedzija G., Elsemore J., Plehn-Dujowich D., McMahon A. P., Flavell R. A., Williams T. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature. 1996 May 16;381(6579):238–241. doi: 10.1038/381238a0. [DOI] [PubMed] [Google Scholar]
  78. Zsebo K. M., Williams D. A., Geissler E. N., Broudy V. C., Martin F. H., Atkins H. L., Hsu R. Y., Birkett N. C., Okino K. H., Murdock D. C. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell. 1990 Oct 5;63(1):213–224. doi: 10.1016/0092-8674(90)90302-u. [DOI] [PubMed] [Google Scholar]
  79. van den Oord J. J., Vandeghinste N., De Ley M., De Wolf-Peeters C. Bcl-2 expression in human melanocytes and melanocytic tumors. Am J Pathol. 1994 Aug;145(2):294–300. [PMC free article] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES